Administration of a Bitter-Tasting Medication: Comparison Between the Rx Medibottle and the Oral Syringe
- Conditions
- Infant Acceptance of Medication
- Interventions
- Device: Rx Medibottle
- Registration Number
- NCT00634374
- Lead Sponsor
- Bronx-Lebanon Hospital Center Health Care System
- Brief Summary
Hypothesis: The Rx medibottle is more effective than the oral syringe when giving infants less than 2 years of age a bitter-tasting medication (prednisolone syrup).
Summary: Infants who were admitted to the pediatric floor with a respiratory illness at the Bronx-Lebanon Hospital were offered the chance to take part in the study. If these children needed prednisolone syrup for their treatment, were less than 2 years old and were bottle-fed, and were in stable condition, they qualified. They were randomly assigned (just by chance), into a control arm, where they received medication using the oral syringe, or an intervention arm, where they were given medication using the Rx medibottle. How well the infant accepted the bitter-tasting medication was compared between the two arms using an infant medication acceptance scale. The scale was administered and a score generated by two raters: the nurse who administered the medication, and a child life therapist who witnessed the administration. The time needed to give the medication, the drug delivery device's ability to administer the entire dose of medication and the mother's satisfaction with the method used were also compared between the two arms.
- Detailed Description
The ability to deliver drugs to infants and children safely and accurately has long been of concern to pediatricians and caregivers. Calibrated oral syringes are accurate in measuring and delivering the required dose, have minimal potential for spillage and are considered the standard drug delivery system for this population. However, infant acceptance of the syringe may not always be favorable. The objective of this study was to compare the Rx medibottle to the oral syringe when used to administer liquid medication to infants. It is a prospective, controlled trial that enrolled infants \<2 years of age admitted to a community hospital in the Bronx, who were prescribed a daily dose of 2 mg/kg of prednisolone syrup (15 mg/5 ml) for a respiratory illness. Participants were randomly assigned to receive one dose of prednisolone syrup using the Rx medibottle (intervention arm) or the oral syringe (control arm). The infant medication acceptance scale (MAS) used to evaluate acceptance by the infants was developed and validated by Donna Kraus, Leslie Stohlmeyer and Patricia Hannon and published in the American Journal of Health-System Pharmacy (1999;16:1094-1101).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 81
- Admitted to the pediatric inpatient unit
- Stable condition
- Bottle fed
- Less than 2 years
- Receiving prednisolone syrup (15 mg/5 ml)
- Breast fed
- Greater than 2 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Rx Medibottle Rx medibottle
- Primary Outcome Measures
Name Time Method Infant acceptance of the bitter-tasting oral liquid medication On the day of enrollment, with use of drug delivery device
- Secondary Outcome Measures
Name Time Method Time needed to administer medication using the drug delivery method Measured at the time of drug administration by stopwatch Maternal satisfaction with drug delivery method At the time of administration or on viewing a videotape of administration Administration of the entire dose of medication with each drug delivery method On the day of enrollment, with use of drug delivery device
Trial Locations
- Locations (1)
Bronx-Lebanon Hospital Center
🇺🇸Bronx, New York, United States